Artelo Biosciences (ARTL) Common Equity (2014 - 2026)
Artelo Biosciences' Common Equity was $6.67 million in Q1 2026, up 923.3% from $652,000 a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Artelo Biosciences came in at -$1.27 million.
- In earlier years, Common Equity was $2.86 million in FY2024 (-75.7%), $11.75 million in FY2023 (-39.4%), $19.4 million in FY2022 (-28.6%) and $27.17 million in FY2021.
- The Q1 2026 figure marks the highest quarterly Common Equity since Q2 2024.
- Compared with a year earlier, Common Equity was higher in 1 of the last five quarters, with growth averaging 128.6%.
- The best year-over-year quarter for Common Equity over five years was Q1 2026 (growth of 923.3%); the worst was Q1 2025 (a decline of 93.2%).
- Per Business Quant data, ARTL's Common Equity in the three quarters before Q1 2026 was -$1.27 million (Q4 2025), -$633,000 (Q3 2025) and -$1.41 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | 5.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 6.67 Mn |
| Dec 31, 2025 | -1.27 Mn |
| Sep 30, 2025 | -633,000.00 |
| Jun 30, 2025 | -1.41 Mn |
| Mar 31, 2025 | 652,000.00 |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 9.54 Mn |
| Dec 31, 2023 | 11.75 Mn |
| Sep 30, 2023 | 14.58 Mn |
| Jun 30, 2023 | 16.27 Mn |
| Mar 31, 2023 | 17.64 Mn |
| Dec 31, 2022 | 19.40 Mn |
| Sep 30, 2022 | 21.90 Mn |
| Jun 30, 2022 | 23.84 Mn |
| Mar 31, 2022 | 25.78 Mn |
| Nov 30, 2021 | 28.29 Mn |
| Aug 31, 2021 | 12.04 Mn |
API Access
Artelo Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();